Eli Lilly Rips Expert For 'Unreliable' Cymbalta Testimony

Law360, New York (May 1, 2015, 6:49 PM EDT) -- Eli Lilly & Co. has argued that a causation expert for the plaintiffs in two lawsuits over its anti-depressant Cymbalta offered "unreliable" testimony at a recent deposition on issues including medical diagnosis for one of the plaintiffs and certain internal company documents. 

In a filing in California federal court, Eli Lilly sought to exclude the testimony of Dr. Joseph Glenmullen, arguing that he lacked the expertise to testify on plaintiff Claudia Herrera's diagnoses for the hormone-related conditions hypothyroidism and perimenopause. The suits by Herrera and plaintiff Nikki Hexum had alleged that Eli Lilly did not adequately warn of the withdrawal risks associated with the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!